anti-WT-1 cancer vaccine (Advaxis)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-WT-1 cancer vaccine (Advaxis)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionWilms' Tumour 1 inhibitors
TargetsWilms' Tumour 1
Therapy Area/IndicationsLymphomaLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAyala Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAyala Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsLymphomaLeukemia

Other Information

ATC CodeN/A
Related LinksN/A